512 related articles for article (PubMed ID: 16105031)
21. Mechanisms of guanylin action via cyclic GMP in the kidney.
Forte LR; London RM; Krause WJ; Freeman RH
Annu Rev Physiol; 2000; 62():673-95. PubMed ID: 10845107
[TBL] [Abstract][Full Text] [Related]
22. The guanylin and uroguanylin peptide hormones and their receptors.
Krause WJ; London RM; Freeman RH; Forte LR
Acta Anat (Basel); 1997; 160(4):213-31. PubMed ID: 9732122
[TBL] [Abstract][Full Text] [Related]
23. Uroguanylin: structure and activity of a second endogenous peptide that stimulates intestinal guanylate cyclase.
Hamra FK; Forte LR; Eber SL; Pidhorodeckyj NV; Krause WJ; Freeman RH; Chin DT; Tompkins JA; Fok KF; Smith CE
Proc Natl Acad Sci U S A; 1993 Nov; 90(22):10464-8. PubMed ID: 7902563
[TBL] [Abstract][Full Text] [Related]
24. Gastrointestinal pain: unraveling a novel endogenous pathway through uroguanylin/guanylate cyclase-C/cGMP activation.
Silos-Santiago I; Hannig G; Eutamene H; Ustinova EE; Bernier SG; Ge P; Graul C; Jacobson S; Jin H; Liong E; Kessler MM; Reza T; Rivers S; Shea C; Tchernychev B; Bryant AP; Kurtz CB; Bueno L; Pezzone MA; Currie MG
Pain; 2013 Sep; 154(9):1820-1830. PubMed ID: 23748116
[TBL] [Abstract][Full Text] [Related]
25. cGMP-activating peptides do not regulate electrogenic electrolyte transport in principal cells of rat CCD.
Schlatter E; Cermak R; Forssmann WG; Hirsch JR; Kleta R; Kuhn M; Sun D; Schafer JA
Am J Physiol; 1996 Dec; 271(6 Pt 2):F1158-65. PubMed ID: 8997389
[TBL] [Abstract][Full Text] [Related]
26. Guanylin peptides: renal actions mediated by cyclic GMP.
Forte LR; London RM; Freeman RH; Krause WJ
Am J Physiol Renal Physiol; 2000 Feb; 278(2):F180-91. PubMed ID: 10662722
[TBL] [Abstract][Full Text] [Related]
27. Regulation of intestinal uroguanylin/guanylin receptor-mediated responses by mucosal acidity.
Hamra FK; Eber SL; Chin DT; Currie MG; Forte LR
Proc Natl Acad Sci U S A; 1997 Mar; 94(6):2705-10. PubMed ID: 9122260
[TBL] [Abstract][Full Text] [Related]
28. Uroguanylin inhibits H-ATPase activity and surface expression in renal distal tubules by a PKG-dependent pathway.
da Silva Lima V; Crajoinas RO; Carraro-Lacroix LR; Godinho AN; Dias JL; Dariolli R; Girardi AC; Fonteles MC; Malnic G; Lessa LM
Am J Physiol Cell Physiol; 2014 Sep; 307(6):C532-41. PubMed ID: 25031022
[TBL] [Abstract][Full Text] [Related]
29. Guanylin-Guanylyl cyclase-C signaling in macrophages regulates mesenteric fat inflammation induced by high-fat diet.
Hasegawa K; Akieda-Asai S; Fujii Y; Bae CR; Yasuda M; Date Y
Endocr J; 2015; 62(10):939-47. PubMed ID: 26249840
[TBL] [Abstract][Full Text] [Related]
30. Increases in guanylin and uroguanylin in a mouse model of osmotic diarrhea are guanylate cyclase C-independent.
Steinbrecher KA; Mann EA; Giannella RA; Cohen MB
Gastroenterology; 2001 Nov; 121(5):1191-202. PubMed ID: 11677212
[TBL] [Abstract][Full Text] [Related]
31. Guanylin peptides and colorectal cancer (CRC).
Camici M
Biomed Pharmacother; 2008 Feb; 62(2):70-6. PubMed ID: 17582727
[TBL] [Abstract][Full Text] [Related]
32. Guanylin regulates chloride secretion in the human gallbladder via the bile fluid.
Kulaksiz H; Schlenker T; Rost D; Stiehl A; Volkmann M; Lehnert T; Cetin Y; Stremmel W
Gastroenterology; 2004 Mar; 126(3):732-40. PubMed ID: 14988827
[TBL] [Abstract][Full Text] [Related]
33. Signal transduction pathways via guanylin and uroguanylin in stomach and intestine.
London RM; Krause WJ; Fan X; Eber SL; Forte LR
Am J Physiol; 1997 Jul; 273(1 Pt 1):G93-105. PubMed ID: 9252514
[TBL] [Abstract][Full Text] [Related]
34. Regulated, side-directed secretion of proguanylin from isolated rat colonic mucosa.
Martin S; Adermann K; Forssmann WG; Kuhn M
Endocrinology; 1999 Nov; 140(11):5022-9. PubMed ID: 10537127
[TBL] [Abstract][Full Text] [Related]
35. Guanylate Cyclase C: A Current Hot Target, from Physiology to Pathology.
Uranga JA; Castro M; Abalo R
Curr Med Chem; 2018; 25(16):1879-1908. PubMed ID: 29210639
[TBL] [Abstract][Full Text] [Related]
36. Role for the membrane receptor guanylyl cyclase-C in attention deficiency and hyperactive behavior.
Gong R; Ding C; Hu J; Lu Y; Liu F; Mann E; Xu F; Cohen MB; Luo M
Science; 2011 Sep; 333(6049):1642-6. PubMed ID: 21835979
[TBL] [Abstract][Full Text] [Related]
37. Distribution of Escherichia coli heat-stable enterotoxin/guanylin/uroguanylin receptors in the avian intestinal tract.
Krause WJ; Freeman RH; Eber SL; Hamra FK; Fok KF; Currie MG; Forte LR
Acta Anat (Basel); 1995; 153(3):210-9. PubMed ID: 8984830
[TBL] [Abstract][Full Text] [Related]
38. Uroguanylin and guanylin peptides: pharmacology and experimental therapeutics.
Forte LR
Pharmacol Ther; 2004 Nov; 104(2):137-62. PubMed ID: 15518884
[TBL] [Abstract][Full Text] [Related]
39. Uroguanylin inhibits proliferation of pancreatic cancer cells.
Kloeters O; Friess H; Giese N; Buechler MW; Cetin Y; Kulaksiz H
Scand J Gastroenterol; 2008; 43(4):447-55. PubMed ID: 18365910
[TBL] [Abstract][Full Text] [Related]
40. The relaxation induced by uroguanylin and the expression of natriuretic peptide receptors in human corpora cavernosa.
Sousa CM; Havt A; Santos CF; Arnaud-Batista FJ; Cunha KM; Cerqueira JB; Fonteles MC; Nascimento NR
J Sex Med; 2010 Nov; 7(11):3610-9. PubMed ID: 20102442
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
